Department of Medicine
Division of Gastroenterology and Hepatology
The Division of Gastroenterology and Hepatology evaluates and treats adult patients with all common as well as complex gastrointestinal problems and offers the full range of state-of-the-art diagnostic and therapeutic procedures.
The division consists of full-time gastroenterologists with significant expertise in various GI and liver disorders. Each physician is committed to providing excellent clinical care to our patients.
Areas of Expertise
- Biliary disease
- Celiac disease (gluten sensitive enteropathy)
- Colon cancer prevention
- Colon polyps
- Endoscopic Ultrasound for assessment of gallstones, gastrointestinal cancer, and biliary and pancreatic cancers
- ERCP to evaluate and treat common bile duct stones, bile duct abnormalities, biliary diseases, and pancreatic duct abnormalities and pancreatic disorders
- Esophageal disease, including motility (swallowing) disorders, gastroesophageal reflux disease (GERD), Barrett’s esophagus and esophageal cancer
- Fatty Liver Disease (NAFLD and NASH)
- Gastrointestinal bleeding
- Hepatitis (Hepatitis C; Hepatitis B; and Autoimmune Hepatitis)
- Inflammatory Bowel Disease—Crohn’s Disease and Ulcerative Colitis
- Interventional Endoscopy for gallstone removal and treatment of biliary and pancreatic strictures
- Obesity (endoscopic approaches to treating obesity, i.e., endoscopic bariatric surgery)
- Pancreatic cancer evaluation
- Peptic ulcer disease and helicobacter pylori
- Pre- and post-liver transplant care
- Primary biliary cholangitis and primary sclerosing cholangitis
- Stomach cancer evaluation
Clinical Academic Building (CAB)
125 Paterson Street, Suite 5100B
New Brunswick, NJ 08901
For Appointments: 732-235-7784
Clinical Director of Hepatology
Clinical Director of Gastroenterology
The gastroenterologists in the Biliary and Pancreas Disease Center, in conjunction with our surgery, radiology, oncology, and pathology colleagues at the center, offer a multi-disciplinary approach to patients with gallstone disease, as well as malignancies of the pancreas and biliary system. Our gastroenterologists use state-of-the-art endoscopic technology, including endoscopic ultrasound, in diagnosing and treating the complications of gallstone disease, as well as malignancies of the pancreas and biliary system.
Endoscopic ultrasound (EUS) is a state-of-the-art technology that combines endoscopy and ultrasound to obtain images of the internal organs in the chest and abdomen and enable the visualization of all layers of the intestinal tract. EUS plays an integral role in determining the stage of gastrointestinal and lung cancers and in detecting bile duct stones. Combined with fine-needle aspiration, EUS is a minimally invasive alternative to exploratory surgery to obtain tissue samples from abdominal and chest organs such as the pancreas, bile ducts, gallbladder, liver, spleen, and chest and abdominal lymph nodes. Our physicians also use EUS to guide pancreatic pseudocyst drainage and provide celiac plexus block for abdominal pain related to chronic pancreatitis or pancreatic cancer.
Clinical Academic Building (CAB)
125 Paterson Street, Room 5133
New Brunswick, NJ 08901
Crohn’s disease and ulcerative colitis, together known as inflammatory bowel disease (IBD), are complex inflammatory diseases of the intestines that affect tens of thousands of patients in New Jersey and 1.5 million across the United States. The Crohn’s and Colitis Center of New Jersey was established more than two decades ago to provide comprehensive and compassionate care for patients with these challenging conditions.
At the Crohn’s and Colitis Center of New Jersey, state -of -the -art diagnostic and endoscopic methods (including colonoscopy, chromoendoscopy, capsule endoscopy, endoscopic balloon dilation of strictures, therapeutic and diagnostic enteroscopy, MRI and CT enterography) are combined with evidence-based clinical approaches, the latest in IBD treatments (including clinical trials), and patient education to provide the IBD patient with the best chance of disease remission. The Center is also home to advanced IBD-related research, including studies focusing on IBD genetics, ethnic variability in IBD, intestinal microbiome and diet related to IBD disease activity, treatment mechanisms, and chemoprevention in IBD. IBD patients benefit from the abundant, multidisciplinary resources provided in the academic setting of Rutgers- Robert Wood Johnson Medical School, including expertise in colorectal surgery, gastrointestinal pathology, radiology, psychiatry, and nutrition.
The IBD experts at the Crohn’s and Colitis Center of New Jersey include Dr. Steven Brant, the Chief of the Division of Gastroenterology and Hepatology, a nationally recognized IBD clinician and a world-renowned IBD geneticist; Dr. Kiron Das, a nationally recognized IBD clinician and physician-scientist; and Dr. Darren Seril, an advanced fellowship-trained IBD clinician.
The Crohn’s and Colitis Center of New Jersey is dedicated to an academic and multidisciplinary approach to providing high quality and compassionate care for IBD patients of New Jersey and beyond.
From disease diagnosis to novel therapies for treatment, our expert team of specialists uses advanced and interventional endoscopic techniques to meet the needs of individuals with a variety of gastrointestinal disorders, from gallstones to the most complex cancers of the gastrointestinal tract. We provide minimally invasive alternatives to surgical or interventional radiology procedures, focusing on improved care and early detection and treatment of these conditions.
Our dedicated, state-of-the-art endoscopy suite enables our specialists to easily integrate cutting-edge technology as they perform the full range of highly advanced procedures.
Our team is led by a world-renowned endoscopist who is pioneering minimally invasive procedures involving therapeutic endosonography, endoscopic treatment of obesity, endoscopic resection and myotomy, nationally and internationally.
The Division offers FibroScan®, a non-invasive, painless aid for managing patients with liver disease. FibroScan is FDA-approved for clinical management of patients with liver disease and is covered by most insurance carriers.
FibroScan works by emitting a pulse of energy, which you may feel as a slight vibration on your skin. FibroScan then measures the speed of this energy and immediately provides this information to your physician, who then uses it as part of a broader evaluation of your liver health.
FibroScan offers many benefits:
- Consistent results
- The examined area is 100x the size of a needle biopsy
- Covered by most insurance plans
- The procedure is painless and takes about 10 minutes
Participating Providers (12)
|Iman Andalib, MD||(732) 235-7784|
|Steven R. Brant, MD||(732) 235-7784|
|Ruby Greywoode, MD||(732) 235-7784|
|Louis H. Griffel, MD||(732) 235-7784|
|Michel Kahaleh, MD||(732) 235-7784|
|Charles Andrew Kistler, MD, PharmD||(732) 235-7784|
|Anish V. Patel, MD||(732) 235-7784|
|Vinod K Rustgi, MD, MPH||(732) 235-7784|
|Avik Sarkar, MD||(732) 235-7784|
|Darren N. Seril, MD, PhD||(732) 235-7784|
|Haroon M Shahid, MD||(732) 235-7784|
|Amy Tyberg, MD||(732) 235-7784|